vs
STANDARD BIOTOOLS INC.（LAB）与YORK WATER CO（YORW）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是YORK WATER CO的1.0倍（$19.6M vs $19.4M），YORK WATER CO净利率更高（26.7% vs -177.4%，领先204.1%），YORK WATER CO同比增速更快（3.2% vs -11.5%），过去两年YORK WATER CO的营收复合增速更高（5.1% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
约克水务公司是一家由投资者所有的公用事业公司，总部位于宾夕法尼亚州约克市，业务覆盖宾夕法尼亚州全境。公司由一群关注消防保障的当地商人于1816年创立，至今已有两百余年的运营历史。
LAB vs YORW — 直观对比
营收规模更大
LAB
是对方的1.0倍
$19.4M
营收增速更快
YORW
高出14.7%
-11.5%
净利率更高
YORW
高出204.1%
-177.4%
两年增速更快
YORW
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $19.4M |
| 净利润 | $-34.7M | $5.2M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 33.2% |
| 净利率 | -177.4% | 26.7% |
| 营收同比 | -11.5% | 3.2% |
| 净利润同比 | -28.8% | 0.5% |
| 每股收益（稀释后） | $-0.09 | $0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABYORW
| Q4 25 | — | $19.4M | ||
| Q3 25 | $19.6M | $20.2M | ||
| Q2 25 | $21.8M | $19.1M | ||
| Q1 25 | $40.8M | $18.3M | ||
| Q4 24 | — | $18.8M | ||
| Q3 24 | $22.1M | $19.6M | ||
| Q2 24 | $22.5M | $18.6M | ||
| Q1 24 | $45.5M | $17.5M |
净利润LABYORW
| Q4 25 | — | $5.2M | ||
| Q3 25 | $-34.7M | $6.2M | ||
| Q2 25 | $-33.5M | $5.1M | ||
| Q1 25 | $-26.0M | $3.6M | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | $-26.9M | $5.9M | ||
| Q2 24 | $-45.7M | $5.0M | ||
| Q1 24 | $-32.2M | $4.3M |
毛利率LABYORW
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
营业利润率LABYORW
| Q4 25 | — | 33.2% | ||
| Q3 25 | -168.5% | 39.1% | ||
| Q2 25 | -118.1% | 37.1% | ||
| Q1 25 | -80.8% | 34.3% | ||
| Q4 24 | — | 35.8% | ||
| Q3 24 | -120.9% | 41.1% | ||
| Q2 24 | -134.5% | 37.9% | ||
| Q1 24 | -132.2% | 35.5% |
净利率LABYORW
| Q4 25 | — | 26.7% | ||
| Q3 25 | -177.4% | 30.6% | ||
| Q2 25 | -153.7% | 26.5% | ||
| Q1 25 | -63.8% | 19.8% | ||
| Q4 24 | — | 27.4% | ||
| Q3 24 | -122.0% | 29.9% | ||
| Q2 24 | -203.3% | 26.8% | ||
| Q1 24 | -70.6% | 24.7% |
每股收益（稀释后）LABYORW
| Q4 25 | — | $0.36 | ||
| Q3 25 | $-0.09 | $0.43 | ||
| Q2 25 | $-0.09 | $0.35 | ||
| Q1 25 | $-0.07 | $0.25 | ||
| Q4 24 | — | $0.36 | ||
| Q3 24 | $-0.07 | $0.41 | ||
| Q2 24 | $-0.12 | $0.35 | ||
| Q1 24 | $-0.27 | $0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $1.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $240.3M |
| 总资产 | $539.6M | $680.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABYORW
| Q4 25 | — | $1.0K | ||
| Q3 25 | $129.4M | $1.0K | ||
| Q2 25 | $158.6M | $1.0K | ||
| Q1 25 | $150.9M | $1.0K | ||
| Q4 24 | — | $1.0K | ||
| Q3 24 | $210.6M | $1.0K | ||
| Q2 24 | $269.8M | $1.0K | ||
| Q1 24 | $287.1M | $3.3M |
总债务LABYORW
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益LABYORW
| Q4 25 | — | $240.3M | ||
| Q3 25 | $399.7M | $238.0M | ||
| Q2 25 | $424.5M | $234.6M | ||
| Q1 25 | $454.6M | $232.1M | ||
| Q4 24 | — | $231.2M | ||
| Q3 24 | $489.3M | $228.7M | ||
| Q2 24 | $510.3M | $225.4M | ||
| Q1 24 | $577.3M | $222.9M |
总资产LABYORW
| Q4 25 | — | $680.9M | ||
| Q3 25 | $539.6M | $667.1M | ||
| Q2 25 | $557.0M | $653.7M | ||
| Q1 25 | $579.6M | $641.8M | ||
| Q4 24 | — | $633.5M | ||
| Q3 24 | $681.5M | $621.4M | ||
| Q2 24 | $708.7M | $610.4M | ||
| Q1 24 | $777.7M | $602.3M |
负债/权益比LABYORW
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $8.4M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | — |
| 自由现金流率自由现金流/营收 | -118.1% | — |
| 资本支出强度资本支出/营收 | 4.5% | — |
| 现金转化率经营现金流/净利润 | — | 1.63× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势，按日历期对齐
经营现金流LABYORW
| Q4 25 | — | $8.4M | ||
| Q3 25 | $-22.2M | $7.8M | ||
| Q2 25 | $-20.7M | $7.6M | ||
| Q1 25 | $-30.3M | $6.0M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | $-27.9M | $7.5M | ||
| Q2 24 | $-39.0M | $6.7M | ||
| Q1 24 | $-62.5M | $6.1M |
自由现金流LABYORW
| Q4 25 | — | — | ||
| Q3 25 | $-23.1M | — | ||
| Q2 25 | $-22.6M | — | ||
| Q1 25 | $-35.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-30.1M | — | ||
| Q2 24 | $-41.0M | — | ||
| Q1 24 | $-63.3M | — |
自由现金流率LABYORW
| Q4 25 | — | — | ||
| Q3 25 | -118.1% | — | ||
| Q2 25 | -103.6% | — | ||
| Q1 25 | -86.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -136.4% | — | ||
| Q2 24 | -182.2% | — | ||
| Q1 24 | -138.9% | — |
资本支出强度LABYORW
| Q4 25 | — | — | ||
| Q3 25 | 4.5% | — | ||
| Q2 25 | 8.7% | — | ||
| Q1 25 | 12.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.2% | — | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | 1.7% | — |
现金转化率LABYORW
| Q4 25 | — | 1.63× | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | — | 1.50× | ||
| Q1 25 | — | 1.65× | ||
| Q4 24 | — | 1.98× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 1.34× | ||
| Q1 24 | — | 1.42× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
YORW
暂无分部数据
